# Morepen Laboratories Ltd (MOREPENLAB)
> Exchange: NSE | Sector: Pharma | ISIN: INE083A01026

## Price
Current Price: ₹42.98
Day Change: +1.08%
52W High: ₹70.4
52W Low: ₹33.47
Market Cap: ₹2,299 Cr

## Valuation
P/E: 23.44
P/B: 1.93
EPS: ₹1.79
Book Value: ₹21.77
Dividend Yield: 0%

## Returns
1Y Return: -12.39%

## Profitability
ROE: 0%
ROCE: 24.53%
Debt/Equity: 0.13
Revenue Growth: 5.7%
Profit Growth: 2%
EBITDA Margin: 5.64%
Operating Margin: 7.42%

## About
Morepen Laboratories Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Morepen Laboratories Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Quarterly Report: Board Meeting Intimation for Q-4 And FY 2026 Results.
- Announcement: Compliances-Reg.24(A)-Annual Secretarial Compliance
- BSE Filing: Compliances-Reg.24(A)-Annual Secretarial Compliance

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:03.547Z
Price History Updated: 2026-05-18T22:58:53.631Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:53.631Z
Quant Updated: 2026-05-18T22:58:53.631Z
Sentiment Updated: 2026-05-18T22:58:53.631Z
Financials Status: current
Financials Updated: 2026-05-19T01:16:57.052Z
Financials Last Attempt: 2026-05-19T01:16:57.052Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹1803.73 Cr
Operating Profit: ₹145.09 Cr (OPM 8.04%)
Net Profit: ₹118.02 Cr
Tax: ₹37.09 Cr

## Annual P&L History
FY25: Rev ₹1803.73Cr | PAT ₹118.02Cr | OPM 8.04%
FY24: Rev ₹1682.13Cr | PAT ₹96.16Cr | OPM 7.44%
FY23: Rev ₹1413.95Cr | PAT ₹38.68Cr | OPM 3.65%

## Balance Sheet (FY25)
Total Assets: ₹1778.1 Cr
Total Liabilities: ₹591.14 Cr
Borrowings: ₹105.1 Cr
Cash: ₹27.38 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Sushil  Suri B.Sc., F.C.A., Chairman & MD
- Sanjay  Suri, Whole-Time Director
- Ajay Kumar Sharma, Chief Financial Officer
- Vivan  Prashar, Functional Head of Operations - API
- Nishant Jayesh Doshi, Vice President – Corporate Finance & Investor Relations

---
Source: rupiya.io/stocks/morepenlab
Disclaimer: For research and education only. Not investment advice.